FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W830743038> ?p ?o ?g. }

• W830743038 endingPage "9630" @default.
• W830743038 startingPage "9621" @default.
• W830743038 abstract "Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has potent antitumor effects in glioma cell lines but has shown little clinical benefit for patients. We investigated whether the widely used chemotherapeutic agent temozolomide (TMZ) can sensitize glioma stem-like cells (GSCs) from human glioblastoma multiforme (GBM) to TRAIL-induced apoptosis. GSCs were isolated from GBM, and stem cell properties were confirmed by immunocytochemistry and in vivo tumorigenicity. Primary GSCs (PGCs) were produced by serum treatment of GBM-derived cells. Changes in expression levels of various TRAIL-related signaling factors before and after TRAIL or TRAIL + TMZ treatment were measured by Western blotting. Overexpression vectors and siRNAs were used to investigate mechanism of TRAIL sensitivity. GSCs showed greater resistance to TRAIL-induced apoptosis than PGCs and had lower basal caspase activity. Caspase knockdown in PGCs reduced TRAIL sensitivity. Expression levels of c-Fas-associated death domain-like interleukin 1-converting enzyme-like inhibitory protein long and short isoforms (c-FLIPL and c-FLIPS) were significantly higher in GSCs than PGCs, and siRNA-mediated c-FLIP knockdown in GSCs enhanced TRAIL-induced apoptosis. TMZ enhanced TRAIL-induced apoptosis in GSCs and downregulated c-FLIP expression. Add of TMZ also upregulated the expression of the E3 ubiquitin ligase casitas B-lineage lymphoma (c-Cbl). Moreover, overexpression of c-Cbl alone reduced c-FLIP expression, and c-Cbl knockdown both enhanced c-FLIP expression and reduced the potentiating effect of TMZ on TRAIL-induced apoptosis. The result indicated that TMZ may overcome TRAIL resistance in GSCs by suppressing c-FLIP expression through c-Cbl-mediated ubiquitination and degradation." @default.
• W830743038 created "2016-06-24" @default.
• W830743038 creator A5001354721 @default.
• W830743038 creator A5026314838 @default.
• W830743038 creator A5045150831 @default.
• W830743038 creator A5056465234 @default.
• W830743038 creator A5060254396 @default.
• W830743038 date "2015-07-06" @default.
• W830743038 modified "2023-09-24" @default.
• W830743038 title "Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein" @default.
• W830743038 cites W134917844 @default.
• W830743038 cites W1826547551 @default.
• W830743038 cites W1854771294 @default.
• W830743038 cites W1924121791 @default.
• W830743038 cites W1967637031 @default.
• W830743038 cites W1967637444 @default.
• W830743038 cites W1987506447 @default.
• W830743038 cites W2001544973 @default.
• W830743038 cites W2007681284 @default.
• W830743038 cites W2011326217 @default.
• W830743038 cites W2018607339 @default.
• W830743038 cites W2018671779 @default.
• W830743038 cites W2022976025 @default.
• W830743038 cites W2029231546 @default.
• W830743038 cites W2031610930 @default.
• W830743038 cites W2033071625 @default.
• W830743038 cites W2041259207 @default.
• W830743038 cites W2041685436 @default.
• W830743038 cites W2051055358 @default.
• W830743038 cites W2062826804 @default.
• W830743038 cites W2068711271 @default.
• W830743038 cites W2071182159 @default.
• W830743038 cites W2071599920 @default.
• W830743038 cites W2082726484 @default.
• W830743038 cites W2087042574 @default.
• W830743038 cites W2094793885 @default.
• W830743038 cites W2098688060 @default.
• W830743038 cites W2098876426 @default.
• W830743038 cites W2106284224 @default.
• W830743038 cites W2110347501 @default.
• W830743038 cites W2114714381 @default.
• W830743038 cites W2116462993 @default.
• W830743038 cites W2117410285 @default.
• W830743038 cites W2133987610 @default.
• W830743038 cites W2141815918 @default.
• W830743038 cites W2151125762 @default.
• W830743038 cites W2167445011 @default.
• W830743038 cites W2167650288 @default.
• W830743038 cites W2169103384 @default.
• W830743038 cites W2328332463 @default.
• W830743038 doi "https://doi.org/10.1007/s13277-015-3720-8" @default.
• W830743038 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26142735" @default.
• W830743038 hasPublicationYear "2015" @default.
• W830743038 type Work @default.
• W830743038 sameAs 830743038 @default.
• W830743038 citedByCount "7" @default.
• W830743038 countsByYear W8307430382017 @default.
• W830743038 countsByYear W8307430382018 @default.
• W830743038 countsByYear W8307430382019 @default.
• W830743038 crossrefType "journal-article" @default.
• W830743038 hasAuthorship W830743038A5001354721 @default.
• W830743038 hasAuthorship W830743038A5026314838 @default.
• W830743038 hasAuthorship W830743038A5045150831 @default.
• W830743038 hasAuthorship W830743038A5056465234 @default.
• W830743038 hasAuthorship W830743038A5060254396 @default.
• W830743038 hasConcept C104317684 @default.
• W830743038 hasConcept C12519072 @default.
• W830743038 hasConcept C127561419 @default.
• W830743038 hasConcept C153911025 @default.
• W830743038 hasConcept C173396325 @default.
• W830743038 hasConcept C185592680 @default.
• W830743038 hasConcept C190283241 @default.
• W830743038 hasConcept C2777389519 @default.
• W830743038 hasConcept C2778227246 @default.
• W830743038 hasConcept C28328180 @default.
• W830743038 hasConcept C31573885 @default.
• W830743038 hasConcept C48297814 @default.
• W830743038 hasConcept C502942594 @default.
• W830743038 hasConcept C55493867 @default.
• W830743038 hasConcept C86803240 @default.
• W830743038 hasConcept C95444343 @default.
• W830743038 hasConceptScore W830743038C104317684 @default.
• W830743038 hasConceptScore W830743038C12519072 @default.
• W830743038 hasConceptScore W830743038C127561419 @default.
• W830743038 hasConceptScore W830743038C153911025 @default.
• W830743038 hasConceptScore W830743038C173396325 @default.
• W830743038 hasConceptScore W830743038C185592680 @default.
• W830743038 hasConceptScore W830743038C190283241 @default.
• W830743038 hasConceptScore W830743038C2777389519 @default.
• W830743038 hasConceptScore W830743038C2778227246 @default.
• W830743038 hasConceptScore W830743038C28328180 @default.
• W830743038 hasConceptScore W830743038C31573885 @default.
• W830743038 hasConceptScore W830743038C48297814 @default.
• W830743038 hasConceptScore W830743038C502942594 @default.
• W830743038 hasConceptScore W830743038C55493867 @default.
• W830743038 hasConceptScore W830743038C86803240 @default.
• W830743038 hasConceptScore W830743038C95444343 @default.
• W830743038 hasIssue "12" @default.

• next